6UYA

Crystal structure of Compound 19 bound to IRAK4

Summary for 6UYA

• Entry DOI: 10.2210/pdb6uya/pdb
• Related: 6O8U
• Descriptor: Interleukin-1 receptor-associated kinase 4, N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide, SULFATE ION, ... (4 entities in total)
• Functional Keywords: kinase, inflammation, lupus, immunology, inhibitor, cancer, signaling protein, signaling protein-inhibitor complex, signaling protein/inhibitor
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 4
• Total formula weight: 146708.21

Authors

Kiefer, J.R.,Bryan, M.C.,Lupardus, P.J.,Zarrin, A.A.,Rajapaksa, N.S.,Gobbi, A.,Drobnick, J.,Kolesnikov, A.,Liang, J.,Do, S. (deposition date: 2019-11-12, release date: 2019-11-20, Last modification date: 2020-04-01)

• Primary citation: Rajapaksa, N.S.,Gobbi, A.,Drobnick, J.,Do, S.,Kolesnikov, A.,Liang, J.,Chen, Y.,Sujatha-Bhaskar, S.,Huang, Z.,Brightbill, H.,Francis, R.,Yu, C.,Choo, E.F.,DeMent, K.,Ran, Y.,An, L.,Emson, C.,Maher, J.,Wai, J.,McKenzie, B.S.,Lupardus, P.J.,Zarrin, A.A.,Kiefer, J.R.,Bryan, M.C.; Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity.; Acs Med.Chem.Lett., 11:327-333, 2020; PubMed: 32184965; DOI: 10.1021/acsmedchemlett.9b00380

Experimental method

X-RAY DIFFRACTION (1.74 Å)